Team Ventures
ViAqua Therapeutics develops orally administered RNA-based treatments that can be mixed into feed to protect shrimp and other aquaculture species against major viral diseases.
Our investment supports a practical disease-management platform that can reduce mortality, improve feed and resource efficiency, protect farmer livelihoods and enable more reliable and sustainable aquaculture production.
“We are attracted to companies that address fundamental bottlenecks in food production. Viral diseases continue to cause significant losses across aquaculture, particularly in shrimp (around 40% of global shrimp production is lost because of disease). We believe ViAqua's technology can become an essential tool for improving animal health and production resilience. Combined with a strong scientific foundation and an experienced team, this creates a compelling opportunity in a market which is poised for long-term structural growth.”
